Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy - PubMed (original) (raw)

Case Reports

Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy

A J Marian et al. J Clin Invest. 1992 Dec.

Abstract

Familial hypertrophic cardiomyopathy (FHCM) is an autosomal dominant disease affecting primarily the myocardium. The gene responsible for FHCM has been localized to chromosome 14 in some families and several mutations have been described in the beta-myosin heavy chain (beta MHC), a candidate gene for the disease. We recently identified a family with HCM in whom we did not detect any of the known mutations in the beta MHC gene (the alpha/beta MHC hybrid gene and the missense mutation in exons 13 and 9). However, we did observe a novel 9.5-kb BamHI restriction fragment length polymorphism detected by a beta MHC probe on Southern blots of DNA from the proband of this family. Similarly, a novel 3.8-kb TaqI polymorphism and a novel 4.3-kb HindIII polymorphism were detected on Southern blots of DNA from the same proband. Polymerase chain reaction (PCR) was used to amplify the segment of the beta MHC that was detected by pSC14 probe. PCR amplification of the distal 3'-end of the beta MHC gene yielded an additional product in the DNA template from the proband which was subsequently cloned and sequenced. The sequence analysis showed a 2.4-kb nucleotide deletion involving one allele of the beta MHC gene. The deletion includes part of the intron 39, exon 40 including the 3'-untranslated region and the polyadenylation signal, and part of the beta-alpha MHC intergenic region. This deletion was inherited in Mendelian fashion in an additional three members of this small family of which only the proband has developed clinically diagnosed HCM at a very late onset (age 59 yr), the other three family members are younger and have not developed the disease at the ages of 10, 32, and 33 yr.

PubMed Disclaimer

Cited by

Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
Mademont-Soler I, Mates J, Yotti R, Espinosa MA, Pérez-Serra A, Fernandez-Avila AI, Coll M, Méndez I, Iglesias A, Del Olmo B, Riuró H, Cuenca S, Allegue C, Campuzano O, Picó F, Ferrer-Costa C, Álvarez P, Castillo S, Garcia-Pavia P, Gonzalez-Lopez E, Padron-Barthe L, Díaz de Bustamante A, Darnaude MT, González-Hevia JI, Brugada J, Fernandez-Aviles F, Brugada R. Mademont-Soler I, et al. PLoS One. 2017 Aug 3;12(8):e0181465. doi: 10.1371/journal.pone.0181465. eCollection 2017. PLoS One. 2017. PMID: 28771489 Free PMC article.
Multiple disease genes cause hypertrophic cardiomyopathy.
Watkins H. Watkins H. Br Heart J. 1994 Dec;72(6 Suppl):S4-9. doi: 10.1136/hrt.72.6_suppl.s4. Br Heart J. 1994. PMID: 7873324 Free PMC article. Review. No abstract available.
Molecular basis of hypertrophic and dilated cardiomyopathy.
Marian AJ, Roberts R. Marian AJ, et al. Tex Heart Inst J. 1994;21(1):6-15. Tex Heart Inst J. 1994. PMID: 8180512 Free PMC article. Review.
Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.
Marian AJ, Salek L, Lutucuta S. Marian AJ, et al. Minerva Med. 2001 Dec;92(6):435-51. Minerva Med. 2001. PMID: 11740432 Free PMC article. Review.
Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
Roopnarine O, Leinwand LA. Roopnarine O, et al. Biophys J. 1998 Dec;75(6):3023-30. doi: 10.1016/S0006-3495(98)77743-4. Biophys J. 1998. PMID: 9826622 Free PMC article.

References

1. J Clin Invest. 1992 Jul;90(1):271-7 - PubMed
1. N Engl J Med. 1987 Oct 15;317(16):985-90 - PubMed
1. Cell. 1990 Sep 7;62(5):991-8 - PubMed
1. Genetics. 1989 Oct;123(2):301-13 - PubMed
1. Cardiol Clin. 1988 May;6(2):233-88 - PubMed

Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy - PubMed (original) (raw)